Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : The Pharmaceutical Journal, 31 January 2015, Vol 294, No 7847

Sort by: Newest first Oldest first A-Z Z-A

  • No more pro-pharmacy rhetoric: we need action Subscription

    22 JAN 2015 15:27 By Graham Phillips

    GP surgeries and accident and emergency departments are under siege. Barely a day goes past without the issue being highlighted in the nation’s media and discussed by politicians of all persuasions. Everyone, it seems, agrees that pharmacy is a significant part of the answer and the Royal Pharmaceutical Society and other pharmacy bodies have done a great job of

  • Male patients with type 2 diabetes, who have a degree and earn more than US$60,000 a here are more likely to take their prescribed medicines, recent survey shows

    Study sheds light on factors affecting adherence in patients with diabetes Subscription

    22 JAN 2015 15:09 By Debbie Andalo
    Comments (1)

    Patients with type 2 diabetes are more likely to take their medicines as prescribed if they are male, have a degree and earn more than US$60,000 a year.

  • Harm from low molecular weight heparins Subscription

    22 JAN 2015 15:04

    NHS England has issued a patient safety alert to remind practitioners of the harm caused from using low molecular weight heparins when they are contraindicated. More information is available from the NHS England website.

  • Administration of ciclosporin not recommended with Olysio Subscription

    22 JAN 2015 15:02

    The summary of product characteristics for Olysio (simeprevir; Janssen-Cilag) now states that co-administration with ciclosporin is not recommended because this leads to significantly higher exposure of simeprevir. 

  • 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol

    Almost 42% of US drinkers report taking drugs that interact with alcohol Subscription

    22 JAN 2015 14:56

    Some 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol, according to research published in Alcoholism: Clinical and Experimental Research.

  • Draft recommendations for sun exposure Subscription

    22 JAN 2015 14:52

    The National Institute for Health and Care Excellence (NICE) is consulting on draft recommendations to help people strike the right balance when it comes to being out in the sun. Communicating the benefits and risks of sunlight exposure to the general public is contentious because exposing the skin to too much time in the sun is a risk for skin cancer but too little can lead to vitamin D deficiency. The draft recommendations aim to give people a better understanding of the various ...

  • Antifungal agents interactions app and databases Subscription

    22 JAN 2015 14:40

    The Fungal Infection Trust and the National Aspergillosis Centre have developed a freely available online resource and app for iPhone, iPad and Android devices, which displays potential interactions between antifungal agents and other medicines. The collaboration supported the development of two databases, one for patients and

  • Polypharmacy guide Subscription

    22 JAN 2015 14:39

    NHS East and South East England specialist pharmacy services have published a guide to managing polypharmacy for all healthcare professionals. The document supports clinical staff, including all sectors of the pharmacy profession, in acute, mental health primary and community care, and commissioners, in helping patients to get the best health outcome through evidence-based medication review.

  • Protamine sulphate injection discontinued Subscription

    22 JAN 2015 14:33

    Protamine sulphate injection 50mg/5ml has been discontinued by RPH Pharmaceuticals. More information is available on 01283 495280.

  • Further delays to Amdipharm Mercury stock Subscription

    22 JAN 2015 14:31

    There have been further delays to the supply of some Amdipharm Mercury products. Trifluoperazine tablets 1mg x 112 are now expected to be back in stock by February 2015. Gentamicin eye/ear drops 0.3% w/v x 10ml and guanethidine monosulphate ampoules 10mg/ml x 5 are expected to be back in stock by March 2015. Gentamicin and hydrocortisone acetate ear drops 0.3%/1% w/v x 10ml are now expected to be back in stock by April 2015. Diloxanide tablets 500mg x 30 are expected by October 2015. 

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.